Laboratory proficiency testing involves the use of prepared samples that are sent to laboratories to test for various analytes like viruses, bacteria, and chemicals. These tests help laboratories evaluate their laboratory practices, identify training needs, validate new methods and troubleshoot problems. The samples contain known analytes and concentrations which allows the laboratories to compare their results against an acceptable target value range. This helps ensure the accuracy and reliability of diagnostic tests being performed. The growing focus on accurate diagnostic testing across different healthcare domains like clinical pathology, microbiology and molecular diagnostics has driven the demand for proficiency testing programs.

The global laboratory proficiency testing market is estimated to be valued at US$ 1.49 billion in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period of 2024 to 2031.

Key players operating in the laboratory proficiency testing market are RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd., Onconova Therapeutics, Genome Protection Inc., Grace Therapeutics LLC, Amgen Inc., Partner Therapeutics Inc., Jubilant Life Sciences Ltd., Cipla Inc., Stium Inc., Soligenix Inc., Aeolus Pharmaceuticals, PharmaIN Corp, and Immune Modulators Inc.

Key Takeaways
Key players: RxBio Inc. is a leading proficiency testing provider known for its accurate and timely sample delivery. Annova Chem Inc. specializes in chemistry testing programs.

Growing demand: Increasing prevalence of chronic diseases is driving more diagnostic testing, propelling the need for Laboratory Proficiency Testing programs. Moreover, regulatory mandates in different regions necessitate the participation of labs in proficiency testing.

Technological advancement: Adoption of innovative sample collection and transport techniques along with cloud-based assessment software solutions are enhancing efficiency and convenience of proficiency testing programs.

The Asia Pacific region has been witnessing fastest growth in the laboratory proficiency testing market over the recent past. Factors such as growing medical tourism industry, increasing healthcare expenditure, widespread healthcare reforms, and expansion of private clinical labs have been contributing to this growth.

Countries like India, China, Japan, and South Korea are key drivers as they are building large diagnostic infrastructures to cater to their large patient pools. During the pandemic, their efforts doubled in developing indigenous COVID-19 diagnostic capabilities and adopting external proficiency testing measures. This boosted the regional market growth opportunities. With continued economic expansions, Asia Pacific is expected to emerge as the most lucrative market for laboratory proficiency testing providers in the long run.

Get more insights on Laboratory Proficiency Testing Market